Related by context. All words. (Click for frequent words.) 74 Adalimumab 73 Dasatinib 72 Abatacept 71 Epoetin Alfa 71 Bevacizumab 70 Monotherapy 70 ACE Inhibitors 70 Pemetrexed 70 Fludarabine 70 Bosutinib 70 Tocilizumab 70 Erlotinib 69 Etanercept 69 Long Term Efficacy 69 Capecitabine 69 Darunavir 69 Rivaroxaban 69 Lenalidomide 69 Gefitinib 69 Shows Efficacy 69 Celecoxib 69 Pfizer Sutent 69 Rituximab 69 Melphalan 69 Tacrolimus 69 tocilizumab 69 Fluorouracil 69 Peginterferon 69 Fluticasone 68 Cyclooxygenase 2 68 Irinotecan 68 Bosentan 68 mycophenolate mofetil 68 Vidaza azacitidine 68 Oral Fingolimod 68 Neoadjuvant 68 Patients Treated 68 Improved Survival 68 Patients Treated With 68 Fondaparinux 68 Lamotrigine 68 Anti TNF 68 Improves Survival 68 Ranolazine 68 Nilotinib 68 Carvedilol 68 Pioglitazone 68 ritonavir boosted 68 Patients Receiving 68 Tipranavir 68 selegiline 68 Chemoradiation 68 Investigational Agent 68 Tiotropium 67 Previously Treated 67 Everolimus 67 Telmisartan 67 Ziprasidone 67 Rheumatoid Arthritis Patients 67 Moxifloxacin 67 FASLODEX 67 Natalizumab 67 Anthracycline 67 Aliskiren 67 Mycophenolate Mofetil 67 alfa 2a 67 Teriparatide 67 Zileuton 67 Posaconazole 67 Omalizumab 67 alpha 2a 67 Fulvestrant 67 Remicade infliximab 67 TNF Tumor Necrosis Factor 67 Bivalirudin 67 Corticosteroids 67 Atacand 67 Azathioprine 67 Donepezil 67 Antitumor Activity 67 Glatiramer Acetate 67 Valsartan 67 PEGylated anti 67 Imatinib 67 Candesartan 67 Romiplostim 67 RoACTEMRA 67 Adjuvant Treatment 67 Traficet EN 67 efalizumab 67 Exemestane 67 Well Tolerated 67 QVAR ® 67 Efficacious 67 Meets Primary Endpoint 67 Protease Inhibitors 67 Naive Patients 67 Phase IIb Trial 67 adalimumab Humira 67 Heart Failure Patients 67 Is Well Tolerated 66 Eculizumab 66 leukotriene receptor antagonist 66 Adjuvant Therapy 66 Nebulized 66 ZOLINZA 66 Methotrexate 66 Salmeterol 66 Ranibizumab 66 Pulmonary Arterial Hypertension 66 Mg Uk 66 Gemcitabine 66 Demonstrated Significant 66 Bortezomib 66 Mirapexin 66 lansoprazole Prevacid 66 Methylprednisolone 66 Complicated Skin 66 Investigational Treatment 66 Decitabine 66 Fingolimod 66 Degarelix 66 Dapagliflozin 66 alefacept 66 KAPIDEX 66 Interferon Beta 66 sertraline Zoloft 66 biologic therapy 66 Cardiotoxicity 66 gastrointestinal stromal tumors GIST 66 Tolerability 66 Newly Diagnosed Multiple Myeloma 66 FOLFOX6 66 Relapsed Refractory 66 Atypical Antipsychotics 66 Lacosamide 66 Hormone Refractory Prostate Cancer 66 Lubiprostone 66 APTIVUS R 66 Crestor rosuvastatin 66 Fluconazole 66 Trastuzumab 66 Combination Therapy 66 Methylnaltrexone 66 aripiprazole Abilify 66 Sorafenib 66 Prilosec omeprazole 66 Pegylated 66 Atomoxetine 66 sorafenib Nexavar 66 Dabigatran 66 Vincristine 66 Boceprevir 66 Improves Outcomes 66 Enoxaparin 66 Cyclophosphamide 66 Severe Sepsis 65 Elderly Patients 65 candesartan cilexetil 65 tipranavir 65 Prolongs Survival 65 Losartan 65 Demonstrates Efficacy 65 ® lenalidomide 65 Zoledronic acid 65 Study Evaluating 65 Pharmacokinetics PK 65 Clopidogrel 65 Golimumab 65 infliximab Remicade 65 Phase III Trial 65 FUSILEV enhances 65 Noxafil 65 Tasigna nilotinib 65 Liver Failure 65 Rosiglitazone 65 Nesiritide 65 Acute Ischemic Stroke 65 Epivir 65 Refractory Hodgkin Lymphoma 65 Treated Patients 65 esomeprazole Nexium 65 tenofovir Viread 65 Pegylated Liposomal Doxorubicin 65 Levofloxacin 65 Progressive Multifocal Leukoencephalopathy 65 Epratuzumab 65 cidofovir 65 TNF inhibitor 65 bevacizumab Avastin 65 rilonacept 65 Mitoxantrone 65 cinacalcet 65 Relapsing Remitting Multiple Sclerosis 65 Vildagliptin 65 irbesartan 65 Glucocorticoid 65 Betaferon R 65 Randomized Study 65 Plaque Psoriasis 65 Teriflunomide 65 angiotensin converting enzyme inhibitors 65 administered subcutaneously 65 adalimumab 65 Darbepoetin Alfa 65 Peginterferon Alfa 2a 65 PROCRIT ® 65 Cytarabine 65 Toremifene 65 Alemtuzumab 65 Dabigatran etexilate 65 Torisel 65 Femara letrozole 65 Sustained Efficacy 65 Pegylated Interferon 65 Montelukast 65 Ramelteon 65 olmesartan 65 Pediatric Patients 65 Metastatic Colorectal Cancer 65 dual endothelin receptor antagonist 65 Tolvaptan 65 INVEGA ® 65 Initiate Clinical Trial 65 glatiramer acetate 65 Cetuximab 65 Lansoprazole 65 Unfractionated Heparin 65 metastatic malignant 65 Diabetic Patients 65 Clinical Trial Evaluating 65 Allopurinol 65 Advagraf 65 Raltegravir 65 ipratropium bromide 65 ALVESCO R 65 Pertuzumab 65 DFMO 65 Aflibercept 65 Taxol paclitaxel 65 Patients Undergoing 65 Appears Safe 65 ATACAND 65 Psoriasis Drug 65 Metastatic Prostate Cancer 65 Low Dose 65 Antipsychotic 65 Drug Candidate 65 Pirfenidone 65 meropenem 65 Improve Survival 65 Tigecycline 65 Topiramate 64 Subcutaneous 64 Known generically 64 Advanced Colorectal Cancer 64 antiplatelet agent 64 Replacement Therapy 64 Sertraline 64 Roche Actemra 64 leukotriene receptor antagonists 64 etanercept Enbrel 64 Eltrombopag 64 Patency 64 Intravesical 64 BANZEL 64 Hydroxyurea 64 Epirubicin 64 Azacitidine 64 Investigational Drug 64 sunitinib Sutent 64 aspirin clopidogrel 64 Itraconazole 64 oral rivaroxaban 64 Adjuvant Chemotherapy 64 briakinumab 64 TO AVOID PREGNANCY WHILE 64 Roche Xeloda 64 Fewer Side Effects 64 Dexamethasone 64 Abciximab 64 Helicobacter pylori eradication 64 Anastrozole 64 Tesamorelin 64 Zarnestra 64 Aortic Stenosis 64 Intravitreal 64 Tumor Response 64 Survival Benefit 64 Camptosar ® 64 Telbivudine 64 Statin Therapy 64 PEGylated Fab fragment 64 Herceptin trastuzumab 64 Amikacin 64 long acting bronchodilator 64 Angioedema 64 R lenalidomide 64 erlotinib Tarceva ® 64 Regimens 64 docetaxel Taxotere ® 64 Single Dose 64 Phase III Clinical Trial 64 Renal Cell Carcinoma 64 Bicalutamide 64 Statistically Significant 64 Subgroup Analysis 64 Pregabalin 64 Oxaliplatin 64 Abacavir 64 Ocrelizumab 64 Adjunctive 64 Pazopanib 64 clomipramine 64 Hypertensive Patients 64 Hepatitis C Genotype 64 Treating Chronic 64 abatacept Orencia 64 dasatinib Sprycel ® 64 riociguat 64 Study Showed 64 immunomodulatory agents 64 adriamycin 64 Rilonacept 64 icatibant 64 Paraplatin ® 64 Cholesterol Lowering Drug 64 Interferon beta 1b 64 Navelbine ® 64 Combination Treatment 64 palifermin 64 TNF alpha inhibitor 64 Olmesartan 64 Mg Usa 64 GW# [003] 64 HMG CoA reductase inhibitors 64 Recombinant Human 64 Blood Pressure Drug 64 Corticosteroid 64 Chronic Myeloid Leukemia 64 DOXIL 64 omeprazole Prilosec 64 Clinical Efficacy 64 Overactive Bladder 64 Previously Untreated 64 Methylphenidate 64 ribavirin RBV 64 rituximab Rituxan 64 Platinol ® 64 Knee Osteoarthritis 64 adefovir dipivoxil 64 Plaquenil 64 Immunosuppressant 64 Aptivus ® 64 clopidogrel Plavix 64 cefuroxime 63 Bisphosphonate 63 peginterferon alfa 63 Quetiapine 63 Bucindolol 63 Proton Pump Inhibitor 63 Adenoma Prevention 63 Significantly Improved 63 Aripiprazole 63 5 Fluorouracil 63 Rofecoxib 63 Anti Tumor Activity 63 Avastin bevacizumab 63 TEMODAL 63 anakinra 63 guanfacine 63 Calcitonin 63 mycophenolate mofetil MMF 63 Vandetanib 63 Improve Outcomes 63 Castration Resistant Prostate Cancer 63 imatinib Gleevec ® 63 Cardiovascular Events 63 Eszopiclone 63 Bupropion 63 interferon gamma 1b 63 gabapentin Neurontin 63 Disease Progression 63 Prophylaxis 63 Oral corticosteroids 63 Carbamazepine 63 Interferon Alpha 63 D aspartate NMDA receptor 63 raloxifene Evista 63 platelet inhibitor 63 cetuximab Erbitux R 63 Desvenlafaxine 63 AZILECT 63 Osteoporosis Drug 63 protease inhibitor PI 63 Extended Release 63 epoetin beta 63 Phase 2a Trial 63 pioglitazone HCl 63 APTIVUS 63 Riluzole 63 Spironolactone 63 DMARDS 63 Autologous Stem Cell Transplantation 63 paclitaxel Taxol 63 Valproate 63 Venlafaxine 63 pimozide 63 JAK Inhibitor 63 Prospective Randomized 63 pyrazinamide 63 ACTEMRA TM 63 nilotinib Tasigna 63 LYSTEDA 63 Fixed Dose 63 esomeprazole 63 thalidomide Thalomid 63 Metronidazole 63 Clinical Trial Results 63 Oral Anticoagulant 63 dexamethasone Decadron 63 Safinamide 63 NICE Recommends 63 cyclosporin 63 oxcarbazepine 63 Hycamtin 63 IRESSA 63 Hepatotoxicity 63 INTEGRILIN R 63 boosted protease inhibitor 63 rituximab 63 Allogeneic 63 Demonstrates Significant 63 immunomodulatory therapies 63 angiotensin receptor blocker ARB 63 Inhaled Corticosteroids 63 FDA Approvals 63 Relapsing Multiple Sclerosis 63 Cimzia certolizumab pegol 63 Adjunctive Therapy 63 Denufosol 63 Phase 2b Study 63 Sunitinib 63 RISPERDAL ® 63 CYT# QbG# 63 Protelos 63 Cinacalcet 63 Anti VEGF 63 Medoxomil 63 HER2 Positive Breast Cancer 63 Pafuramidine 63 salmeterol fluticasone 63 Non Steroidal Anti Inflammatory 63 PULMICORT RESPULES 63 mitoxantrone plus 63 Myelodysplastic Syndromes 63 Daptomycin 63 angiotensin II receptor blocker 63 Vfend 63 Certolizumab 63 BoNTA 63 Cilostazol 63 Maribavir 63 denileukin diftitox 63 Sitagliptin 63 Combination therapy 63 Demonstrates Positive 63 Pramlintide 63 Immunosuppression 63 Janssen Risperdal 63 Treatment Regimen 63 Interferon beta 63 Phase III Trials 63 diclofenac Voltaren 63 Rheumatoid Arthritis Drug 63 trastuzumab Herceptin 63 Cyclosporine 63 AVASTIN 63 Docetaxel 63 Certolizumab pegol 63 Venous Thromboembolism 63 Didanosine 63 Sanofi Aventis Taxotere 63 Doxil ® 63 amifostine 63 Diabetic Neuropathy 63 Fracture Risk 63 Node Positive 63 Epidermal Growth Factor Receptor 63 Catapres 63 Treatment Naive Patients 63 AVANDIA 63 PRISTIQ 63 Fungal Infections 63 Generic Versions 63 paricalcitol 63 CIMZIA TM certolizumab pegol 63 paliperidone palmitate 63 Zoledronic Acid 63 strontium ranelate 63 immunosuppressant drug 63 PKC# 63 AZILECT R 63 nonsteroidal 63 Combo Therapy 63 Hepatitis B Vaccine 63 Advanced Prostate Cancer 63 LEXIVA 63 MabCampath 63 II Clinical Trial 63 Investigational Compound 63 PROCRIT R 63 colesevelam HCl 63 Therapy Reduces 63 amprenavir 63 calcineurin inhibitor 63 visilizumab 63 Telithromycin 63 Bendamustine 63 Kidney Transplant Patients 63 FDA APPROVES 63 VAPRISOL 63 Peginterferon Alfa 2b 63 nilotinib 63 FDA Okays 63 Febuxostat 63 ACE Inhibitor 63 Ustekinumab 63 Multiple Myeloma Patients 63 Pradaxa ® 63 Sustained Release 63 Diovan HCT 63 Trabectedin 63 pregabalin 63 AZT zidovudine Retrovir 63 Analgesic 63 captopril 63 Paliperidone Palmitate 63 Ticagrelor 63 Mesalamine 62 Tyrosine Kinase Inhibitor 62 BARACLUDE ® 62 COPAXONE R 62 octreotide acetate 62 Firazyr 62 HFA MDI 62 Lamivudine 62 paroxetine Paxil 62 flecainide 62 sunitinib Sutent ® 62 AstraZeneca Iressa 62 bortezomib Velcade 62 Topotecan 62 benazepril 62 See CLINICAL PHARMACOLOGY 62 Slow Progression 62 MEVACOR 62 PEG IFN 62 Severe Asthma 62 pioglitazone Actos 62 Antiviral Activity 62 Sandostatin R 62 Nitazoxanide 62 PROMACTA 62 Atypical Hemolytic Uremic Syndrome 62 Peginterferon alfa 2b 62 Doxorubicin 62 Diuretic 62 Orally Active 62 Breast Cancer Recurrence 62 Phase 2b Clinical Trial 62 Pharmacokinetic Study 62 Proton Pump Inhibitors 62 primidone 62 CIMZIA TM 62 Beta Blockers 62 basiliximab 62 Nucleoside 62 Malignant Glioma 62 CHOP chemotherapy 62 NDA Submission 62 sorafenib tablets 62 lapatinib Tykerb 62 ARIXTRA 62 Amlodipine 62 azathioprine 62 docetaxel Taxotere 62 NAVISTAR R 62 Isotretinoin 62 Lotensin 62 Anti Tumor 62 Myelodysplastic Syndrome MDS 62 Eraxis 62 Lopid 62 alkylating agent 62 Celebrex celecoxib 62 Hypercholesterolemia 62 Antiplatelet 62 Randomised 62 peginterferon alpha 2a 62 Taxotere ® 62 Ropinirole 62 Receptor Antagonists 62 pegylated liposomal doxorubicin 62 epoetin alfa 62 WelChol 62 Neuroprotective Effects 62 leflunomide 62 Neupro R 62 Temsirolimus 62 rFVIIa 62 weekly subcutaneous injections 62 Captopril 62 Sipuleucel T 62 Chronic Sinusitis 62 Hepatitis C Patients 62 Carboplatin Paclitaxel 62 haloperidol Haldol 62 superficial bladder cancer 62 Prednisone 62 Chronic Hepatitis B 62 HCV Protease Inhibitor 62 Kinoid 62 Colorectal Cancer Patients 62 Clolar ® 62 voriconazole 62 Beta Blocker 62 Pegasys ® 62 anti arrhythmic drug 62 Pneumococcal Vaccine 62 Resistant Hypertension 62 Phase 2a Clinical Trial 62 Fludara ® 62 fluvastatin 62 topical calcineurin inhibitors 62 Cancidas 62 Dalbavancin 62 uric acid lowering 62 lumiliximab 62 Drug Eluting Stents 62 Risedronate 62 Fenofibrate 62 Orphan Status 62 divalproex sodium 62 relapsing multiple sclerosis 62 Esomeprazole 62 Platelet Inhibition 62 pemetrexed Alimta 62 ara C 62 CYP#A# inhibitors 62 Sapacitabine 62 Adefovir 62 Hsp# Inhibitor 62 TYKERB 62 Tarceva TM 62 R adalimumab 62 pegylated interferon alfa 2a 62 baminercept 62 Cellcept 62 acarbose 62 Isoniazid 62 Renal Artery 62 Kepivance 62 B Cell Lymphoma 62 Zemplar 62 cediranib 62 acute bronchospasm 62 Shows Promise Against 62 Lopinavir 62 Rheumatoid 62 Radiofrequency Ablation 62 Darusentan 62 fludarabine cyclophosphamide 62 HYPERTENSION 62 nicardipine 62 Paroxetine 62 pregabalin Lyrica 62 PEGASYS ® 62 Advanced Renal Cell 62 relapsed MM 62 baclofen 62 Taxotere docetaxel 62 Anticoagulant 62 Treatment Naive HIV 62 ORENCIA ® 62 tigecycline 62 Leucovorin 62 metformin HCl 62 infliximab 62 Effectively Treats 62 Tumor Growth 62 NSAID diclofenac 62 Hydralazine 62 Lanthanum Carbonate 62 SPRYCEL ® 62 levosimendan 62 Chronic Hepatitis C 62 N acetylcysteine 62 Follicular Lymphoma 62 Ezetimibe 62 Angiotensin Converting Enzyme 62 Imuran 62 FOLFIRI 62 Benign Prostatic Hyperplasia 62 alendronate Fosamax 62 AMEVIVE 62 DORIBAX 62 xanthine oxidase inhibitor 62 Pivotal Study 62 pimecrolimus 62 Brilique 62 Paxil paroxetine 62 tipranavir ritonavir 62 rosuvastatin Crestor 62 Pegloticase 62 Cholesterol Drug 62 Lung Cancer Patients 62 Diabetic Nephropathy 62 Antihistamine 62 Receives Orphan Drug Designation 62 levetiracetam Keppra 62 Fluoxetine 62 Laquinimod 62 MAXALT 62 Entecavir 62 peg interferon 62 serotonin norepinephrine reuptake inhibitor 62 amitriptyline Elavil 62 tiotropium bromide 62 Vidofludimus 62 Ribavirin 62 Intelence 62 CIMZIA R 62 Atacand ® 62 DAPT 62 Dose Escalation 62 Anemia Drug 62 Triptans 62 Alkeran 62 Androgen Deprivation Therapy 62 Vimpat R 62 Rheumatoid Arthritis RA 62 Coadministration 62 prucalopride 62 pegylated interferon alfa 62 Humira adalimumab 62 cis retinoic acid 62 Bevacizumab Avastin 62 RAPAMUNE 62 Muraglitazar 62 inhibit platelet function 62 Solid Tumors 62 Hydrochlorothiazide 62 Levaquin levofloxacin 62 Cholesterol Drugs 62 cetuximab Erbitux ® 62 Zoloft sertraline 62 PEGINTRON TM 62 Cimetidine 62 Paliperidone ER 62 Sandostatin LAR 62 Shows Statistically Significant 62 Pooled Analysis 62 Risperidone 62 Peg IFN 61 Daclizumab 61 Tapentadol 61 Carboplatin 61 Pharmacodynamics 61 Restenosis 61 Gout Drug 61 Orphan Designation 61 Erythropoietin 61 glitazones 61 Amrubicin 61 Novel Compound 61 CONTRAINDICATIONS 61 Carbidopa 61 LAMICTAL 61 Bayer Onyx 61 EGFR TKI 61 suppressive therapy 61 Parnate 61 bevacizumab Avastin ® 61 budesonide 61 cholinesterase inhibitors 61 fulvestrant 61 nucleoside analog 61 abacavir Ziagen 61 Myelofibrosis 61 deferoxamine 61 antiarrhythmic drug 61 Pramipexole 61 Thromboembolism 61 Pegylated interferon 61 Duloxetine 61 fluorouracil 61 dopamine receptor agonist 61 Significantly Improves 61 Rosuvastatin 61 Skeletal Muscle 61 6 mercaptopurine 61 Schizophrenia Treatment 61 zolmitriptan 61 Romidepsin 61 pegylated 61 AMN# [001] 61 standard chemotherapy regimen 61 Immunomodulatory 61 Enbrel Humira 61 Simvastatin 61 ReoPro 61 acute GvHD 61 Non Responders 61 Ofatumumab 61 Gleevec imatinib 61 Roflumilast 61 Pixantrone 61 ULTRAM ER 61 Advanced Melanoma 61 idarubicin 61 TMS Therapy 61 efavirenz EFV 61 Chronic Bronchitis 61 Blinatumomab 61 Pivotal Phase III 61 Hepatic Impairment 61 Ritonavir 61 Enlarged Prostate 61 Novel Mechanism 61 mapatumumab 61 Treatment Resistant 61 CYT# potent vascular disrupting 61 Haloperidol 61 LT NS# 61 Randomized Controlled Trials 61 immunomodulatory therapy 61 oxaliplatin Eloxatin 61 Platinol ® cisplatin 61 KRN# 61 Sycrest 61 fluvastatin Lescol 61 Ischemic Stroke 61 IN PATIENTS WITH 61 Desvenlafaxine Succinate 61 Roche Pegasys 61 Estrogen Receptor 61 INVEGA ™ 61 bezafibrate 61 VFEND 61 short acting bronchodilator 61 chemotherapy cisplatin 61 DEXILANT 61 SEROQUEL XR 61 glatiramer 61 Treatment Reduces 61 LIALDA 61 Mitomycin C 61 Dose Ranging Study 61 Placebo Controlled Trial 61 HCV Genotype 61 Theophylline 61 Zebinix 61 Generalized Anxiety Disorder 61 Invasive Breast Cancer 61 tolterodine ER 61 nizatidine 61 mometasone 61 Lipid Lowering 61 lacosamide 61 Sodium oxybate 61 Protease Inhibitor 61 Cimzia TM 61 Preclinical Data 61 Mipomersen 61 gemcitabine Gemzar 61 anticlotting drugs 61 recurrent GBM 61 eltrombopag 61 INTELENCE 61 propranolol Inderal 61 dasatinib Sprycel 61 Ketorolac 61 liposome injection 61 Crizotinib 61 abacavir lamivudine 61 Radiofrequency Ablation RFA 61 Anticancer Activity 61 gefitinib Iressa 61 Blood Thinner 61 cisplatin gemcitabine 61 Xelox 61 Sporanox 61 risperidone Risperdal 61 idiopathic thrombocytopenic purpura ITP 61 ACTOS ® 61 lovastatin Mevacor 61 DU #b 61 Allergic Rhinitis 61 Verapamil 61 Warfarin Coumadin 61 PLAVIX 61 AVAPRO 61 Ivabradine 61 topiramate Topamax 61 Mouse Model 61 Cell Lymphoma CTCL 61 imatinib therapy 61 donepezil Aricept 61 Proves Effective 61 FIRMAGON 61 administered concomitantly 61 HERCEPTIN 61 Hypotension 61 tipifarnib 61 Kuvan sapropterin dihydrochloride 61 Bare Metal Stent 61 ß blockers 61 aprepitant 61 Chronic Constipation 61 Starlix 61 Cardiovascular Outcomes 61 mesylate 61 Cisplatin 61 Capsules CII 61 omalizumab 61 Genentech Rituxan 61 Epilepsy Drug 61 venlafaxine Effexor 61 unfractionated heparin UFH 61 Skin Structure Infections 61 Danazol 61 interferon ribavirin 61 Disease Modifying 61 monoamine oxidase inhibitors 61 prochlorperazine 61 estramustine 61 Neulasta ® 61 RhuDex 61 dalteparin 61 Efficacy Trial 61 ibandronate 61 Progenitor Cells 61 Cutaneous T 61 Hepatocellular Carcinoma 61 canakinumab 61 intravenously administered 61 Glimepiride 61 INFERGEN 61 INCB# [003] 61 mTOR inhibitor 61 tinidazole 61 rosiglitazone maleate 61 COPEGUS R 61 Relapsed 61 guanfacine extended release 61 Demonstrates Potent 61 Gleevec imatinib mesylate 61 PegIntron 61 Paclitaxel Carboplatin 61 NeoRecormon 61 Sustained Reduction 61 olanzapine Zyprexa 61 oral antidiabetic drugs 61 nab paclitaxel 61 Higher Doses 61 mesalazine 61 Significantly Reduced 61 interferon alfa 2b 61 H2 antagonists 61 topically administered 61 Granted Orphan Drug 61 Metabolic Disorder 61 Multidrug 61 Abrupt discontinuation 61 Prophylactic 61 teriflunomide 61 Liver Injury 61 EMSAM 61 CIMZIA ™ 61 Minocycline 61 Thiazolidinediones 61 Percutaneous Coronary Intervention 61 Cardiac Resynchronization 61 infusional 61 atazanavir 61 zonisamide SR 61 FEMALES SHOULD BE ADVISED 61 Bayer Nexavar 61 Drug Fails 61 laropiprant 61 refractory chronic lymphocytic 61 Axid 61 Lung Cancer Drug 61 C Reactive Protein 61 SUSTENNA TM 61 Colchicine 61 Chronic HCV 61 Renal Impairment